Can H. pylori–associated gastritis impair folate absorption and raise homocysteine when dietary folate is borderline?

Chronic Helicobacter pylori (H. pylori) infection is a well-established cause of gastritis that can lead to significant nutrient malabsorption, specifically affecting folate and Vitamin B12. This impairment creates a metabolic bottleneck that often manifests as elevated homocysteine levels, particularly in individuals with suboptimal dietary intake.

Clinical and effectiveness evidence

Large-scale meta-analyses consistently show that individuals infected with H. pylori have significantly lower serum folate levels compared to uninfected controls, with standardized mean differences (SMD) reaching approximately -0.69.

• Correlation with Severity: The degree of folate depletion directly correlates with the severity and extent of gastric inflammation. Patients with pan-mucosal gastritis (inflammation throughout the stomach) exhibit more pronounced deficiencies than those with localized or inactive gastritis.
• Impact on Homocysteine: Clinical data indicate that H. pylori positivity is a strong predictor of hyperhomocysteinemia (elevated homocysteine). Correcting folate status through supplementation or H. pylori eradication typically results in a significant reduction in homocysteine levels (often by 25% or more in those with low baseline folate).

Mechanistic explanations

The link between H. pylori and folate deficiency is driven by alterations in the gastric environment:

• pH-Dependent Absorption: Dietary folate (polyglutamate) must be converted to monoglutamate by the enzyme γ-glutamyl hydrolase before it can be absorbed. This enzyme requires an acidic environment. H. pylori causes gastritis and potential mucosal atrophy, leading to hypochlorhydria (reduced stomach acid). When gastric pH rises above 6.0, folate deconjugation and subsequent absorption are severely impaired.
• One-Carbon Metabolism: Folate, in the form of 5-methyltetrahydrofolate (5-MTHF), serves as a critical methyl donor for the enzyme methionine synthase. This enzyme converts homocysteine back into methionine.
• The Metabolic Bottleneck: When H. pylori reduces folate bioavailability, there is insufficient 5-MTHF to support the remethylation of homocysteine. This causes homocysteine to accumulate in the blood, a process that is exacerbated when dietary intake is already "borderline" or low, as the body has no physiological reserve to compensate for the malabsorption.

Bottom line

H. pylori–associated gastritis is scientifically proven to impair folate absorption by raising gastric pH, which directly contributes to higher homocysteine levels. This effect is most clinically significant in individuals with borderline dietary folate, where the combination of poor intake and malabsorption leads to a failure in homocysteine metabolism.